definiens: ( b ) Each of the following terms is defined in the Section or under the definedterm set forth opposite such term below : ABI ............................................................. Preamble ADE ......................................................... Section 9.02 Agreement ....................................................... Preamble Clinical Records ......................................... Section 2.01(c ) Disputed Amount .......................................... Section 5.03(a ) DMF ...................................................... Section 2.02(b ) Effective Date .................................................. Preamble Force Majeure .............................................. Section 16.08 BME ............................................................. Preamble Indemnitee ................................................. Section 13.03 Indemnitor ................................................. Section 13.03 Interferon ...................................................... Recitals Loss ....................................................... Section 13.01 Parties ......................................................... Preamble Party ........................................................... Preamble Patent Rights ............................................. Section 10.01 Purchase Price .............................................. Section 7.01 Representatives ............................................ Section 15.01 Royalty Payment Date ........................................ Section 4.02 Milestone Payments .......................................... Section 4.03 SEC ........................................................ Section 15.02 SOP ......................................................... Section 9.02 Term ........................................................ Section 5.01 CONFIDENTIAL * * * * Indicates that a portion of the text has been omitted and filed separatelywith the Commission